Discontinuation of topical corticosteroids in upadacitinib-treated patients with moderate-to-severe atopic dermatitis: analysis from the AD Up phase III trial

被引：0

作者：

Reich, K. ^{[1
]}

Boguniewicz, M. ^{[2
]}

Kabashima, K. ^{[3
]}

Barbarot, S. ^{[4
]}

Girolomoni, G. ^{[5
,6
]}

Mendes-Bastos, P. ^{[7
]}

Gamelli, A. ^{[8
]}

Liu, Y. ^{[8
]}

Teixeira, H. ^{[8
]}

Armstrong, A. ^{[9
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res, Translat Res Inflammatory Skin Dis, Hamburg, Germany

[2] Natl Jewish Hlth, Denver, CO USA

[3] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan

[4] Nantes Univ, CHU Nantes, Dept Dermatol, Nantes, France

[5] Univ Verona, Dept Med Dermatol, Verona, Italy

[6] Univ Verona, Venereol Sect, Verona, Italy

[7] Hosp CUF Descobertas, Dermatol Ctr, Lisbon, Portugal

[8] AbbVie Inc, N Chicago, IL USA

[9] Univ Southern Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

475

引用

页码：E118 / E118

页数：1